Countouriotis Athena
SEC insider (Form 3/4/5 filer). CIK 0001571469. Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in SAN RAFAEL, CA.
Companies Countouriotis Athena has filed insider reports for
- IOVANCE BIOTHERAPEUTICS, INC. (IOVA): Director
- BIOMARIN PHARMACEUTICAL INC (BMRN): Director
- Passage BIO, Inc. (PASG): Director
Countouriotis Athena
CIK: 0001571469
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 16, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectDeferred Restricted Stock Unit
90.3K shares- - Jun 2, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
AwardDirect7.5K shares- - May 19, 2026PASG
Passage BIO, Inc.
AwardDirectDirector Stock Option (right to buy)
10.5K shares- - Jun 13, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectDeferred Restricted Stock Unit
67.5K shares- - May 28, 2025PASG
Passage BIO, Inc.
AwardDirectDirector Stock Option (right to buy)
201.9K shares- - May 20, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
AwardDirect6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Deferred Restricted Stock Unit | 90,316 | - | - | Direct |
| Jun 2, 2026 |  BMRN BIOMARIN PHARMACEUTICAL INC | Award | 7,490 | - | $0 | Direct |
| May 19, 2026 |  PASG Passage BIO, Inc. | Award Director Stock Option (right to buy) | 10,539 | - | - | Direct |
| Jun 13, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Deferred Restricted Stock Unit | 67,546 | - | - | Direct |
| May 28, 2025 | PASG Passage BIO, Inc. | Award Director Stock Option (right to buy) | 201,857 | - | - | Direct |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award | 6,650 | - | - | Direct |
1-6 of 6 transactions